| Julia M Amann, AUD | |
|
350 Henry Clay Blvd, Lexington, KY 40502-1024 | |
| (859) 268-4545 | |
| (859) 269-1857 |
| Full Name | Julia M Amann |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 9 Years |
| Location | 350 Henry Clay Blvd, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700267531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | SLPAUD00218771 (Kentucky) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | HISHSP00223883 (Kentucky) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Hearing And Speech Center Inc. | 7618103177 | 3 |
News Archive
American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Burlington Anesthesia Associates, a physician group practice that provides anesthesia services in Mt. Holly, NJ.
In this post in the "Health Affairs Blog," diplomacy and global health consultant Judith Kaufmann writes about the Global Polio Eradication Initiative (GPEI) Independent Monitoring Board quarterly report released last week, stating, "What is really new about this report ... is that it does not, as so many GPEI reports have in the past, point the finger at lack of funding, although there is an obvious concern about the funding gap. Rather, the report looks squarely at changes needed in the management of the global program itself."
A study, by Dr Julian Trollor and Dr Tracy Anderson from the School of Psychiatry at UNSW, found that elderly participants (those aged 65 and above) reported a lower prevalence of psychiatric and anxiety disorders and had lower levels of psychological distress than middle-aged participants.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
› Verified 1 days ago
| Provider Name | Lexington Hearing And Speech Center Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265560973 PECOS PAC ID: 7618103177 Enrollment ID: O20131112001017 |
News Archive
American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Burlington Anesthesia Associates, a physician group practice that provides anesthesia services in Mt. Holly, NJ.
In this post in the "Health Affairs Blog," diplomacy and global health consultant Judith Kaufmann writes about the Global Polio Eradication Initiative (GPEI) Independent Monitoring Board quarterly report released last week, stating, "What is really new about this report ... is that it does not, as so many GPEI reports have in the past, point the finger at lack of funding, although there is an obvious concern about the funding gap. Rather, the report looks squarely at changes needed in the management of the global program itself."
A study, by Dr Julian Trollor and Dr Tracy Anderson from the School of Psychiatry at UNSW, found that elderly participants (those aged 65 and above) reported a lower prevalence of psychiatric and anxiety disorders and had lower levels of psychological distress than middle-aged participants.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julia M Amann, AUD 350 Henry Clay Blvd, Lexington, KY 40502-1024 Ph: (859) 268-4545 | Julia M Amann, AUD 350 Henry Clay Blvd, Lexington, KY 40502-1024 Ph: (859) 268-4545 |
News Archive
American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Burlington Anesthesia Associates, a physician group practice that provides anesthesia services in Mt. Holly, NJ.
In this post in the "Health Affairs Blog," diplomacy and global health consultant Judith Kaufmann writes about the Global Polio Eradication Initiative (GPEI) Independent Monitoring Board quarterly report released last week, stating, "What is really new about this report ... is that it does not, as so many GPEI reports have in the past, point the finger at lack of funding, although there is an obvious concern about the funding gap. Rather, the report looks squarely at changes needed in the management of the global program itself."
A study, by Dr Julian Trollor and Dr Tracy Anderson from the School of Psychiatry at UNSW, found that elderly participants (those aged 65 and above) reported a lower prevalence of psychiatric and anxiety disorders and had lower levels of psychological distress than middle-aged participants.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
› Verified 1 days ago
Paula King Evans, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2387 Professional Heights Drive, Suite 30, Lexington, KY 40503 Phone: 859-276-4838 | |
University Of Kentucky Communicative Disorders Audiologist Medicare: Not Enrolled in Medicare Practice Location: 740 S Limestone, Suite B303, Lexington, KY 40536 Phone: 859-257-3390 Fax: 859-323-5951 | |
Sydney Rieman Nance, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1720 Nicholasville Rd Ste 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-277-0541 | |
Shantel J. Dever, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Nicholasville Rd, Suite 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-278-3774 | |
Dr. Courtney Lynn Cooper, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Veterans Dr, Lexington, KY 40502 Phone: 859-281-4972 | |
Abby B. Mattingly, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone St, Suite B317, Lexington, KY 40536 Phone: 859-257-3390 Fax: 859-323-5951 | |
Trey Anthony Cline, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky Department Of, B317 Kentucky Clinic, Lexington, KY 40536 Phone: 859-218-2176 |